title: Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
authors.affiliation: Service des Innovations Thérapeutiques Précoces, South-Paris University; Departments of Cancer Medicine. Electronic address: jean-charles.soria@igr.fr.
authors.forename: J-C
authors.initials: JC
authors.lastname: Soria
authors.affiliation: Service des Innovations Thérapeutiques Précoces, South-Paris University; Radiation Therapy, Institut Gustave Roussy, Villejuif, France.
authors.forename: E
authors.initials: E
authors.lastname: Deutsch
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002277:Carcinoma; D005260:Female; D006396:Hematemesis / Q000139:chemically induced*; D006469:Hemoptysis / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000628:therapy*; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib